NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
1.
NATURE
OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES:
Nature of
Business Operations
- Simtek Corporation (the "Company") designs,
develops, markets and subcontracts the production of high performance
nonvolatile semiconductor memory products. The Company's operations have
concentrated on the design and development of the 1-megabit, 256-kilobit,
64-kilobit, and 16-kilobit nonvolatile semiconductor memory product families and
associated products and technologies as well as the development of sources of
supply and distribution channels. In 2007, the Company produced initial
samples of its new 4 megabit product and began development of a new very high
density nonvolatile random access memory.
Reverse Stock
Split and Reincorporation
On October 5, 2006, the Company completed a
1 for 10 reverse stock split. All share and per share amounts have been
restated to reflect the effect of the reverse stock split as if it had occurred
as of the balance sheet date or as of the beginning of each fiscal period
presented. In addition, on October 5, 2006, the Company converted from a
Colorado corporation to a Delaware corporation. This reincorporation had
no effect on the consolidated financial statements.
Liquidity
- During 2007 the Company incurred a net loss of $2,768,000 and has accumulated
deficits of $50,966,000 as of December 31, 2007. The Company was also not
in compliance with certain covenants related to financial ratios for its
debentures throughout 2007, but was successful in obtaining waivers from the
debenture holders.
The Company operates
in a volatile industry, whereby its average selling prices and product costs are
influenced by competitive factors. Furthermore, the Company continues to
incur significant research and development costs for product development.
These factors create pressures on sales, costs, earnings and cash flows,
which will impact liquidity.
If the Company is
unable to achieve sufficient cash flow in 2008 it may result in increased
liquidity pressure on the Company, whereby it might be required to enter into
debt or equity arrangements that may not be as otherwise favorable to the
Company.
Revenue
Recognition
- Product sales revenue is recognized when a valid purchase
order has been received with a fixed price and the products are shipped to
customers FOB origin (Colorado Springs, Colorado, Manilla, Philipines or
Dresden, Germany), including distributors. Based on historic business with
the majority of the Company's customers and, in the case of new customers, based
on credit checks, the Company is reasonably assured that collectability on our
shipments will occur. Customers receive a one-year product warranty and sales to
distributors are subject to a limited product exchange program and price
protection in the event of changes in the Company's product prices. The
Company provides a reserve for possible product returns, product price
protection and warranty costs at the time the sale is recognized. The
Company has a detailed procedure to ensure that its estimates for reserves are
reasonable and reliable. The reserve for product returns is based on upon
historical credits issued for actual stock rotation returns from the Companys
distributors. The Company's distributors are permitted to rotate up to 5% of
their stock every six months with the stipulation that they must submit a
replacement order of equal dollar value to the stock that they are returning.
The reserve for price protection is used when the Company authorizes
special pricing to one of its distributors for a specific customer. To
date, the estimates have not been materially different from the credits the
Company has issued under these reserves.
50
SIMTEK CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
Revenue from
royalties related to non-refundable prepaid royalty payments is recognized upon
receipt. Revenue from royalties related to sales of products by license partners
is recognized upon the notification to us of shipment of product from the
Company's technology license partners to direct customers.
Fair Value of
Financial instruments
- The Company's short-term financial
instruments consist of cash, accounts receivable, and accounts payable and
accrued expenses. The carrying amounts of these financial instruments
approximate fair value because of their short-term maturities. Financial
instruments that potentially subject the Company to a concentration of credit
risk consist principally of cash and accounts receivable.
The Company does not
hold or issue financial instruments for trading purposes nor does it hold or
issue interest rate or leveraged derivate financial instruments.
Cash and Cash
Equivalents
- The Company considers all highly liquid investments with
an original maturity of three months or less to be cash equivalents. As of
December 31, 2007, substantially all of the Company's cash and cash equivalents
were held by three banks, of which approximately $3,352,000 was in excess of
Federally insured amounts.
Receivables and
Credit Policies
- Trade receivables consist of uncollateralized customer
obligations due under normal trade terms, typically requiring payment within 30
to 60 days of the invoice date. Management reviews trade receivables
periodically and reduces the carrying amount by a valuation allowance that
reflects managements best estimate of the amount that may not be
collectible.
Inventory
- The Company records inventory using the lower of cost (first-in, first-out) or
market. Inventories consist of (in thousands of dollars):
|
|
|
|
|
|
|
December 31,
|
|
2007
|
|
2006
|
|
|
|
|
Raw
materials
|
$
|
39
|
|
$
|
21
|
Work in
progress
|
4,447
|
|
4,603
|
Finished
goods
|
1,535
|
|
2,737
|
|
6,021
|
|
7,361
|
Less reserves
for excess inventory
|
(323)
|
|
(765)
|
|
$
|
5,698
|
|
$
|
6,596
|
Non-competition
Agreement
- On December 30, 2005, the Company entered into a
non-competition agreement with ZMD as part of the acquisition of ZMDs nvSRAM
product line. The Company assigned a value of $8,910,000 to the
non-competition agreement in December 2005. The value assigned to the
non-competition agreement is being amortized on a straight line basis over its
five year life. During 2007, the Company expensed approximately $1,782,000
to sales and marketing for amortization of the non-competition agreement and
will expense this same amount for each of the next three years.
Goodwill
- Goodwill represents the excess of the total amount paid to ZMD for the
nvSRAM assets acquired on December 30, 2005 and the fair value assigned to
specific assets. This amount will not be amortized, but will be reviewed
for impairment on a periodic basis. As of December 31, 2007, no
impairment of value has been recorded.
51
SIMTEK CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
Depreciation
& Amortization
- Equipment and furniture are recorded at cost.
Depreciation is provided over the assets' estimated useful lives of three
to seven years using the straight-line and accelerated methods. The cost
and accumulated depreciation of furniture and equipment sold or otherwise
disposed of are removed from the accounts and the resulting gain or loss is
included in operations. Maintenance and repairs are charged to operations
as incurred and betterments are capitalized. During the years ending
December 31, 2007 and December 31, 2006, the Company incurred costs of
approximately $106,000 and $70,000, respectively related to the filing of 15 new
patent applications in 2007 and 10 new patent applications in 2006 with
the United States Patent and Trademark Office. The Company will amortize
the costs related to these patents over the life of the patent.
Research and
Development Costs
- Research and development costs are charged to
operations in the period incurred. Total research and development costs
for the years ending December 31, 2007, December 31, 2006 and December 31, 2005
were $8,758,000, $5,855,000 and $6,369,000, respectively.
Advertising
- The Company incurs advertising expense in connection with the marketing of its
product. Advertising costs are expensed as incurred. Advertising
expense was $87,000, $47,000 and $66,000 in 2007, 2006 and 2005, respectively.
Loss Per
Share
- Basic Earnings Per Share ("EPS") is calculated by dividing the
income or loss available to common shareholders by the weighted average number
of common shares outstanding for the period. Diluted EPS reflects the potential
dilution that could occur if securities or other contracts to issue common stock
were exercised or converted into common stock. As the Company incurred
losses in 2007, 2006 and 2005, all common stock equivalents would be considered
anti-dilutive. For purposes of calculating diluted EPS, 4,951,879,
4,425,489 and 1,800,446 options and warrants for 2007, 2006 and 2005,
respectively, were excluded from diluted EPS as they had an anti-dilutive
effect.
Accounting
Estimates
- The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the amounts
reported in the financial statements and the accompanying notes. Future
actual results could differ from those estimates. The Company's financial
statements are based upon a number of significant estimates, including the
allowance for doubtful accounts, technological obsolescence of inventories, the
estimated useful lives selected for property and equipment, sales returns,
warranty reserve, the valuation allowance on the deferred tax assets and
possible impairment of goodwill.
Concentration
of Credit Risk
- Financial instruments that potentially subject the
Company to significant concentration of credit risk consist primarily of
accounts receivable. The Company has no significant off-balance sheet
concentrations of credit risk. Accounts receivable are typically unsecured
and are derived from transactions with and from customers located worldwide.
Impairment of
Long-Lived Assets
- In the event that facts and circumstances indicate
that the cost of assets may be impaired, an evaluation of recoverability would
be performed. If an evaluation is required, the estimated future
undiscounted cash flows associated with the asset would be compared to the
asset's carrying amount to determine if a write-down to market value or
discounted cash flow value is required. As of December 31, 2007, the Company has
incurred no such losses.
52
SIMTEK CORPORATION
NOTES TO
CONSOLIDATED FINANCIAL
STATEMENTS
Accumulated
other comprehensive income (loss)
- The functional currency for
Simtek GmbH is its local currency, the Euro. Assets and liabilities for
this foreign subsidiary are translated at the exchange rate in effect at the
balance sheet date, and income and expenses are translated at average exchange
rates prevailing during the period. Translation gains or losses are
included within shareholders equity as part of accumulated other comprehensive
income (loss). As of December 31, 2007, the Company recorded approximately
$328,000 in comprehensive income.
Principles of
Consolidation
- The accompanying financial statements include the
consolidation of accounts for the Companys wholly owned subsidiary, Simtek
GmbH. All significant inter-company accounts and transactions have been
eliminated in consolidation.
Stock-Based
Compensation
At December 31, 2007, the Company had three stock-based
compensation plans, which are more fully described in Note 6 of these Notes to
Consolidated Financial Statements below.
Prior to January 1,
2006, the Company accounted for awards granted under stock-based compensation
plans using the intrinsic method of expense recognition, which follows the
recognition and measurement principles of Accounting Principles Board (APB)
Opinion No. 25,
Accounting for Stock Issued to Employees
. As
such, compensation expense was recorded on the date of grant if the current
market price of the underlying stock exceeds the exercise price. Under the
provisions of APB 25, there was no compensation expense resulting from the
issuance of stock options by the Company as the exercise price was equivalent to
the fair market value at the date of grant.
Effective January 1,
2006, the Company adopted the fair value recognition provisions of Statement of
Financial Accounting Standard 123(R) Share-Based Payment (SFAS 123(R)) using
the modified prospective transition method. In addition, the Securities and
Exchange Commission issued Staff Accounting Bulletin No. 107 Share-Based
Payment (SAB 107) in March, 2005, which provides supplemental SFAS 123(R)
application guidance based on the views of the SEC. Under the modified
prospective transition method, compensation cost recognized in the twelve month
periods ending December 31, 2007 and 2006 includes: (a) compensation cost
for all share-based payments granted prior to, but not yet vested as of January
1, 2006, based on the grant date fair value estimated in accordance with the
original provisions of SFAS No. 123, and (b) compensation cost for all
share-based payments granted beginning January 1, 2006, based on the grant date
fair value estimated in accordance with the provisions of SFAS 123(R). In
accordance with the modified prospective transition method, results for prior
periods have not been restated.
The stock
compensation expense related to all stock-based compensation plans for the years
ended December 31, 2007 and 2006 was $1,406,000 and $542,000, respectively.
The Company did not recognize a tax benefit from the stock compensation
expense because the Company considers it is more likely than not that the
related deferred tax assets, which have been reduced by a full valuation
allowance, will not be realized.
The Company granted
nonqualified stock options at an exercise price equal to the fair market value
of the Companys common stock on the grant date. The Company applies the
Black-Scholes valuation method to compute the estimated fair value of the stock
options and recognizes compensation expense, net of estimated forfeitures on a
straight-line basis so that the award is fully expensed at the vesting date.
For shares issued under the Employee Stock Purchase Plan, the expense is
recognized as of the date of grant, pursuant to SFAS 123(R).
53
SIMTEK CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
Income
Taxes
- The Company adopted the provisions of FASB Interpretation
No. 48, Accounting for Uncertainty in Income Taxes (FIN 48), on
January 1, 2007. As a result of the implementation of FIN 48, the Company
recognized no adjustments to liabilities or shareholders equity.
When tax returns are
filed, it is highly certain that some positions taken would be sustained upon
examination by the taxing authorities, while others are subject to uncertainty
about the merits of the position taken or the amount of the position that would
be ultimately sustained. Under FIN 48, the benefit of an uncertain tax position
is recognized in the financial statements in the period during which, based on
all available evidence, management believes it is more likely than not that the
position will be sustained upon examination, including the resolution of appeals
or litigation processes, if any. Tax positions taken are not offset or
aggregated with other positions. Tax positions that meet the
more-likely-than-not recognition threshold are measured as the largest amount of
tax benefit that is more than 50 percent likely of being realized upon
settlement with the applicable taxing authority. The portion of the benefits
associated with tax positions taken that exceeds the amount measured as
described above is reflected as a liability for unrecognized tax benefits in the
accompanying balance sheets along with any associated interest and penalties
that would be payable to the taxing authorities upon examination. As of
December 31, 2007, the Company has not recorded any such liability.
The Company files
consolidated income tax returns in the U.S. federal jurisdiction, several state
jurisdictions and the Federal Republic of Germany. The Company is not aware of
any jurisdictions where they would be subject to U.S. federal or state income
tax examinations by tax authorities for years before 2004.
Our policy is
that we recognize interest and penalties accrued on any uncertain tax benefits
as a component of income tax expense. As of the date of adoption of FIN 48, we
did not have any accrued interest or penalties associated with any uncertain tax
benefits, nor was any interest expense recognized during the year.
The Company
recognizes deferred income tax assets and liabilities for the expected future
income tax consequences, based on enacted tax laws, of temporary differences
between the financial reporting and tax bases of assets, liabilities and
carryovers. Deferred tax expense represents the change in the
deferred tax asset/liability balance. Valuation allowances are recorded for
deferred tax assets which, more likely than not, are not expected to be
realized.
The Companys
subsidiary located in Dresden, Germany is required to pay various forms of taxes
including income and corporate taxes to its German taxation authority. The
estimated liability for these taxes was $141,000 and $33,000 at December 31,
2007 and 2006, respectively.
Recently Issued
Accounting Pronouncements
In June 2006, the
FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income
Taxes ("FIN 48"). The interpretation clarifies the accounting for
uncertainty in income taxes recognized in a company's financial statements in
accordance with Statement of Financial Accounting Standards No. 109, Accounting
for Income Taxes. Specifically, the pronouncement prescribes a recognition
threshold and a measurement attribute for the financial statement recognition
and measurement of a tax position taken or expected to be taken in a tax return.
The interpretation also provides guidance on the related
derecognition, classification, interest and penalties, accounting for interim
periods, disclosure and transition of uncertain tax positions. The
interpretation is effective for fiscal years beginning after December 15, 2006.
Please read Note 8 to the Consolidated Financial Statements for a discussion of
FIN 48.
54
SIMTEK CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
In December 2007, the
Financial Accounting Standards Board ("FASB") issued SFAS No. 141 (Revised
2007), "Business Combinations" ("SFAS No. 141(R)"). SFAS No. 141(R)
significantly changes the accounting for business combinations in a number of
areas including the treatment of contingent consideration, acquired
contingencies, transaction costs, in-process research and development and
restructuring costs. In addition, under SFAS No. 141(R), changes in an
acquired entity's deferred tax assets and uncertain tax positions after the
measurement period will impact income tax expense. SFAS No. 141(R) applies
prospectively to business combinations for which the acquisition date is on or
after the beginning of the first annual reporting period beginning after
December 15, 2008. Earlier adoption is prohibited. The Company will adopt
this pronouncement in the first quarter of fiscal 2009 and is currently
evaluating the potential impact of this pronouncement on its consolidated
financial statements.
In December
2007, the FASB issued SFAS No. 160, "Noncontrolling Interests in
Consolidated Financial StatementsAn Amendment of ARB No. 51" ("SFAS
No. 160"), which establishes new accounting and reporting standards for the
noncontrolling interest in a subsidiary, changes in a parent's ownership
interest in a subsidiary and the deconsolidation of a subsidiary. SFAS
No. 160 is effective for fiscal years beginning after December 15,
2008. Earlier adoption is prohibited. The Company will adopt this pronouncement
in the first quarter of fiscal 2009 and is currently evaluating the potential
impact of this pronouncement on its consolidated results of operations and
financial condition.
On March 19, 2008,
The Financial Accounting Standards Board issued FASB Statement No. 161,
Disclosures about Derivative Instruments and Hedging Activities.
The new standard is intended to improve financial reporting about
derivative instruments and hedging activities by requiring enhanced disclosures
to enable investors to better understand their effects on an entitys financial
position, financial performance, and cash flows. It is effective for
financial statements issued for fiscal years and interim periods beginning after
November 15, 2008, with early application encouraged. We are reviewing the
applicability of this Statement and will adopt this pronouncement in the first
quarter of fiscal 2009 if it is applicable.
In November 2007, the
EITF issued Issue No. 07-1 Accounting for Collaboration Arrangements
Related to the Development and Commercialization of Intellectual Property
(EITF 07-1). EITF 07-1 is focused on how the parties to a collaborative
agreement should account for costs incurred and revenue generated on sales to
third parties, how sharing payments pursuant to a collaboration agreement should
be presented in the income statement and certain related disclosure questions.
EITF 07-1 is effective for fiscal years beginning after December 15,
2008. The Company will adopt this pronouncement in the first quarter of fiscal
2009 and is currently evaluating the potential impact of this Issue on its
consolidated results of operations and financial condition.
In February 2007, the
FASB issued SFAS No. 159, "The Fair Value Option for Financial Assets and
Financial Liabilities" ("SFAS No. 159"), which permits entities to choose
to measure eligible financial instruments and certain other items at fair value
that are not currently required to be measured at fair value. Unrealized gains
and losses on items for which the fair value option has been elected are
reported in earnings at each subsequent reporting date. SFAS No. 159 is
effective for fiscal years beginning after November 15, 2007. The Company
will adopt this pronouncement in the first quarter of fiscal 2008 and is
currently evaluating the potential impact of the pronouncement on its
consolidated results of operations and financial condition.
55
SIMTEK CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
In September 2006,
the FASB issued SFAS No. 157, "Fair Value Measurements" ("SFAS
No. 157"), which clarifies the definition of fair value, establishes
guidelines for measuring fair value, and expands disclosures regarding fair
value measurements. SFAS No. 157 does not require any new fair value
measurements and eliminates inconsistencies in guidance found in various prior
accounting pronouncements. SFAS No. 157, as originally issued, was
effective for fiscal years beginning after November 15, 2007. However, in
February 2008, the FASB deferred the effective date of SFAS No. 157 for one
year as it relates to non-financial assets and liabilities that are recognized
or disclosed at fair value in the financial statements on a non-recurring basis.
The Company will adopt SFAS No. 157 as it relates to financial assets and
liabilities in the first quarter of fiscal 2008 and is currently evaluating the
potential impact of the pronouncement on its consolidated financial condition
and results of operations.
2.
EQUIPMENT
AND FURNITURE:
Equipment and furniture at
December 31, 2007 and 2006 consisted of the following:
|
|
|
|
|
|
|
|
December 31,
|
|
2007
|
|
2006
|
(in thousands
of dollars)
|
|
|
|
Leased
equipment under capital leases
|
$
|
36
|
|
$
|
-
|
Research and
development equipment
|
2,954
|
|
2,399
|
Computer
equipment and software
|
2,997
|
|
2,452
|
Office
furniture
|
136
|
|
69
|
Other
equipment
|
448
|
|
232
|
|
6,571
|
|
5,152
|
Less
accumulated depreciation
and
amortization
|
(4,584)
|
|
(3,913)
|
|
$
|
1,987
|
|
$
|
1,239
|
The cost of equipment
and furniture acquired for research and development activities that has
alternative future use is capitalized and depreciated over its estimated useful
life.
Depreciation and
amortization expense of $671,000, $494,000 and $433,000 was charged to
operations for the years ended December 31, 2007, 2006 and 2005, respectively.
Included in the amortization expense for 2007 and 2005 was $1,000 and
$91,000, respectively, of amortization of software and research and development
equipment under capital leases. During 2006, there was no amortization
expense related to software and research and development equipment under capital
leases, as those leases terminated in 2005.
3.
CONVERTIBLE
DEBENTURES:
On July 1, 2002, the
Company received funding of $3,000,000 in a financing transaction with
Renaissance Capital Growth and Income Fund III, Inc., Renaissance US Growth
Investment Trust PLC and US Special Opportunities Trust PLC. RENN Capital
Group, Inc. is the agent for the RENN investment funds. One of the Companys
directors holds the position of Senior Vice President of RENN Capital Group. The
$3,000,000 funding consists of convertible debentures with a 7-year term at a
7.5% per annum interest rate. Each fund equally invested $1,000,000.
The holder of the debenture shall have the right, at any time, to convert
all, or in multiples of $100,000, any part of the Debenture into fully paid and
nonassessable shares of Simtek Corporation common stock. The debentures
were originally convertible into Simtek common stock at $3.12 per share, which
was in excess of the market price per share on July 1, 2002. At December
31, 2007, the Company was not in compliance with one of the covenants set forth
56
SIMTEK CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
in the loan
agreement. This covenant relates to the interest coverage ratio. On
February 8, 2008, the Company received a waiver for the covenant through January
1, 2009. However, significant variances in future actual operations from
the Companys current estimates could result in the reclassification of this
note to current liabilities. The Convertible Debentures allows for an
adjustment in the conversion price, if the Company issues Common Stock in
connection with an equity financing, where the sale price is less than the
conversion price of $3.12. This occurred in December 2005 in connection
with the common stock sale of $11,000,000 at a price of $1.60 per share.
Pursuant to the terms of the 2002 convertible debentures, the Company
agreed with the RENN Capital Group that the conversion price would be reduced to
$2.20 per share. At December 31, 2007, based on the conversion rate
of $2.20 per share, each RENN investment fund is entitled to 318,182 shares upon
conversion (assuming conversion of $700,000).
On June 28, 2005, the
Company received a waiver from the debenture holders extending until July 1,
2006 the commencement date for principal payments of the $3 million aggregate
principal amount, see Note 6 Shareholders Equity for additional information.
On May 9, 2007 and July 24, 2006, each of the debenture holders
converted $200,000 and $100,000, respectively, of the principal amount into
90,910 and 45,455, respectively, shares of the Companys common stock in lieu of
the Company making the principal payments it was required to make commencing on
July 1, 2006.
4.
NOTES
PAYABLE:
On June 2, 2006, the
Company secured a $3.6 million revolving line of credit by entering into an
Account Purchase Agreement (the Agreement) with Wells Fargo Bank, National
Association (Wells Fargo). Pursuant to the Agreement, the Company may
sell, subject to recourse in the event of nonpayment, up to $3.6 million of
eligible accounts receivable to Wells Fargo. Advances of the purchase
price for the eligible receivables will be at an agreed upon discount to the
face value of the eligible receivable. The amount actually collected on
any receivable by Wells Fargo that is beyond the advance will be forwarded to
the Company, less certain discounts and fees retained by Wells Fargo (including
a minimum fee of $7,500 per month for the term of the Agreement). To
secure the Companys obligations under the Agreement, the Company granted Wells
Fargo a security interest in certain of the Companys property. The
Agreement has a term of two years, but may be terminated at any time by the
Company upon 60 days written notice. As of December 31, 2007, the Company
had financed receivables with Wells Fargo for approximately $543,000.
5.
COMMITMENTS:
Offices
Leases
- The Company leases office space in Colorado Springs, Colorado;
Poway, California; and Simtek GMBH leases office space in Dresden, Germany under
leases which expire on February 28, 2013, March 14, 2011 and March 31, 2009,
respectively. Combined monthly lease payments are approximately $35,000.
The Company also has
various fixed term license agreements for computer software design tools.
Future lease payments
under the noncancellable equipment, software design tool license agreements and
office leases described above are as follows:
57
SIMTEK
CORPORATION
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS
|
|
|
Years
Ending
December
31,
|
(in
thousands)
|
2008
|
$
|
1,121
|
2009
|
759
|
2010
|
515
|
2011
|
233
|
2012
& After
|
247
|
|
$
|
2,875
|
Total expenses for
office rent, equipment lease and software design tool license agreements totaled
$1,324,000, $884,000 and $732,000 for the years ended December 31, 2007, 2006
and 2005, respectively.
Employment
Agreements
-
Mr. Blomquist is employed as President and Chief Executive
Officer pursuant to an employment arrangement with the Company. The
Company is currently in the process of documenting an employment agreement with
Mr. Blomquist. The employment arrangement currently provides as set forth
below. Mr. Blomquist receives an annual salary of $325,000 and such
additional benefits that are generally provided other employees. Mr.
Blomquist will be eligible to receive a yearly cash bonus, based on performance,
of up to 100% of his salary. In addition, Mr. Blomquist will receive a
yearly bonus of options to purchase between 10,000 and 40,000 shares of the
Companys common stock; the exact amount will be based on performance.
Upon beginning employment, Mr. Blomquist received options to purchase
250,000 shares of the Companys common stock and a $50,000 cash bonus.
Within four months of beginning employment, Mr. Blomquist was required to
purchase 20,000 shares of common stock from the Company. For each share of
common stock Mr. Blomquist purchased from the Company within six months of
beginning employment, including the 20,000 shares he was required to purchase,
the Company granted him an additional share. Mr. Blomquist purchased a
total of 47,500 shares and the Company granted him 47,500 matching shares.
The Company recorded a total expense of $190,350 for the matching shares,
the expense has been included in general and administrative expenses during the
year ended December 31, 2005. Upon termination, Mr. Blomquist will be
restricted from competing against the Company for a period of 18 months.
If Mr. Blomquist is terminated by the Company without cause, all of Mr.
Blomquists unvested stock options will immediately vest and he will be
reimbursed for out of pocket expenses incurred in moving his family to
California. He may also be entitled to receive between zero dollars, on
the one hand, and his base salary, benefits, and cash and stock bonuses for 18
months on the other hand. If Mr. Blomquist terminates employment due to a
breach by the Company or as a result of constructive termination relating to a
change of control of the Company, all of Mr. Blomquists unvested stock options
will immediately vest and he will continue to receive his base salary, benefits
and cash and stock bonuses for 18 months.
6.
SHAREHOLERS EQUITY:
On
October 5, 2006, Simtek completed a 1 for 10 reverse stock split of all of its
outstanding common shares. All share and per share amounts have been
restated to reflect the effect of the reverse stock split as if it had occurred
as of the balance sheet date or as of the beginning of each fiscal period
presented.
On
September 21, 2006, the Company raised gross proceeds of $4,555,000 in a private
placement. The Company issued 1,153,171 shares of its common stock at a
per share price of $3.95 and 172,981 warrants to purchase common stock.
The warrants have a per share exercise price of $5.40 and a five-year
term. The Company used the proceeds for general working capital purposes.
58
SIMTEK CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
On March 24, 2006,
the Company entered into a License and Development Agreement with Cypress
pursuant to which, among other things, Cypress agreed to license certain
intellectual property from the Company to develop and manufacture standard,
custom, and embedded nvSRAM products. Cypress agreed to pay to Simtek
royalties across all products they develop and sell which include intellectual
property licensed from Simtek. The Company agreed to license from Cypress
certain of their intellectual property for use in the Companys design efforts.
The Company agreed with Cypress to co-develop certain nvSRAM products and
Cypress agreed to pay the Company $4 million in nonrefundable prepaid royalties,
$2 million of which was received at the time the contract was executed. On
June 30, 2006, the Company received the second installment of $1 million in
prepaid royalties and the remaining $1 million was paid on December 18, 2006.
In addition, the Company agreed with Cypress to work together to develop
new products and processes. As part of the agreement, the Company issued
to Cypress, warrants to acquire 2 million shares of the Companys common stock
for $7.50 per share. The warrants have a ten year life. The Company
allocated $1,930,000 of the $4 million prepayment to the value of the warrants
issued. The value was determined using the Black Scholes option-pricing
model.
On December 30, 2005,
the Company closed the sale of 6,875,000 shares of its common stock for an
aggregate purchase price of $11,000,000, pursuant to the terms of the Securities
Purchase Agreement dated as of December 30, 2005, among Simtek and Crestview
Capital Master LLC, as lead investor, Renaissance Capital Growth & Income
Fund III, Inc., Renaissance US Growth Investment Trust PLC, US Special
Opportunities Trust PLC, SF Capital Partners Ltd., Straus Partners, LP, Straus
GEPT Partners, LP and various other individual and institutional investors.
The Company used the majority of the proceeds of this offering to fund the
ZMD Asset Acquisition. The Company also executed a registration rights
agreement with the purchasers, pursuant to which the Company has agreed to
register under the Securities Act the resale by the purchasers of the shares
issued to them. The registration rights agreements contain cash penalties
equal to 2% per month beginning in May 2006 in the event the Company fails to
maintain an effective registration statement with the Securities and Exchange
Commission. As of December 31, 2007, the Company has been in compliance
with the requirements of the registration rights agreement. At
December 31, 2005 there was an outstanding subscription in the amount of
$1,900,000 related to the transaction. This amount plus $641,000 of
transaction related costs have been deducted from the total amount of the
transaction. The $1,900,000 was received by the Company on January 3,
2006.
On December 30, 2005,
the Company issued 626,072 shares of its common stock to ZMD, at a stated value
of $2 million, based on the volume weighted average price of the common stock
for the 60 trading days prior to the execution date of the Asset Purchase
Agreement on December 7, 2005. For accounting and financial reporting
purposes, the shares issued to ZMD were valued at $3.00 per share, pursuant to
Emerging Issues Task Force 99-12 Determination of the Measurement Date for the
Market Price of Acquirer Securities Issued in a Purchase Business Combination,
resulting in an accounting value of $1,882,000. The Company also executed
a registration rights agreement with ZMD, pursuant to which it has agreed to
register under the Securities Act the resale by ZMD of the shares issued to
them.
On May 5, 2005, the
Company closed a Share Purchase Agreement for a $4 million private placement of
674,082 shares of its common stock with Cypress and a Development and Production
Agreement with Cypress to jointly develop a 0.13-micron
Silicon-Oxide-Nitride-Oxide-Silicon (SONOS) nonvolatile memory process.
The Company and Cypress entered into an Escrow Agreement with Cypress
pursuant to which the Company deposited $3 million into an escrow account in
order to support and make certain payments for the 0.13-micron process and
product developments. As of December 31, 2007, $991,000 remained in the escrow
account. Cypress also received a warrant to purchase 505,562
shares of our common stock at $7.772 per share with a term of 10 years. We
have granted to Cypress certain registration rights with respect to the shares
issued under the Share Purchase Agreement and the shares issuable upon exercise
of the warrant.
59
SIMTEK
CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
On June 28, 2005, the
Company received a waiver from the debenture holders extending until July 1,
2006 the commencement date for principal payments of the $3 million aggregate
principal amount 7.5% convertible debentures issued by the Company in 2002.
The original terms of the debentures required the Company to make monthly
principal payments of $10 per $1,000 of the then remaining principal amount,
beginning on June 28, 2005. The Company is still required to make interest
payments. Under the terms of the waiver, monthly principal payments of
$13.33 per $1,000 of the then remaining outstanding principal amount commenced
on July 1, 2006. The final maturity date remains as June 28, 2009.
As consideration for the extension, the Company has issued to the
debenture holders warrants to purchase 20,000 shares of Simtek common stock at
$5.00 per share, a premium to the market price on the date of the waiver. The
Company estimated the value of the warrants at the time of grant, using the
Black Scholes option-pricing model, to be approximately $62,000. The
Company recognized $16,000 as additional interest expense for the period ending
December 31, 2007. See Note 3 Convertible Debentures for additional
information.
On May 10, 2006, the
Company received a waiver letter from the debenture holders, which was issued to
the Company due to the Company not being in compliance with two of the covenants
defined in the loan agreement. As consideration for the waiver letter, the
Company has issued to the debenture holders warrants to purchase 5,000 shares of
Simtek common stock at $3.30 per share. The Company estimated the value of the
warrants at the time of grant, using the Black-Scholes option-pricing model, to
be approximately $11,000. The Company recognized $4,000 as additional
interest expense for the period ending December 31, 2007.
In May 2006, the
Company entered into a $3,600,000 revolving credit agreement with Wells Fargo
Business Credit. As part of this credit agreement the debenture holders
were required to enter into a subordination agreement with Wells Fargo. As
consideration for the subordination agreement, the Company has issued to the
debenture holders warrants to purchase 20,000 shares of Simtek common stock at
$3.30 per share. The Company estimated the value of the warrants at the time of
grant, using the Black-Scholes option-pricing model, to be approximately
$43,000. The Company recognized $21,000 as additional interest expense for
the period ending December 31, 2007.
On May 26, 2006, the
Company issued to the following individuals, who are directors of Simtek, as
compensation for serving as directors of Simtek under Simteks standard
compensation arrangement for directors, the following amounts of shares of
Simtek common stock: Robert Keeley (3,376); Alfred Stein (3,376); Ronald Sartore
(3,376); Robert Pearson (3,376); and Harold Blomquist (371). The expense
for these shares was recorded at the time the compensation was earned by the
directors.
60
SIMTEK CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
Warrants
- A
summary of the warrants outstanding as of December 31, 2007, is as
follows:
|
|
|
|
|
|
|
|
Warrant
Holder
|
Description
|
Issue
Date
|
#
of
Warrants
Outstanding
|
|
Expiration
Date
|
Per
Warrant
Exercise
Price
|
Extended
Value of
Warrants
|
US
Special Opportunities Trust Plc.
|
Warrants
|
11/7/2003
|
12,500
|
|
11/7/2008
|
$12.50
|
$ 156,250
|
US
Special Opportunities Trust Plc.
|
Warrants
|
11/7/2003
|
12,500
|
|
11/7/2008
|
$15.00
|
$ 187,500
|
Renaissance
US Growth
InvestmentTrust Plc.
|
Warrants
|
11/7/2003
|
12,500
|
|
11/7/2008
|
$12.50
|
$ 156,250
|
Renaissance
US Growth
Investment Trust Plc.
I
|
Warrants
|
11/7/2003
|
12,500
|
|
11/7/2008
|
$15.00
|
$ 187,500
|
Renaissance
Capital Growth &
Income Fund III
|
Warrants
|
11/7/2003
|
12,500
|
|
11/7/2008
|
$12.50
|
$ 156,250
|
Renaissance
Capital Growth &
Income Fund III
|
Warrants
|
11/7/2003
|
12,500
|
|
11/7/2008
|
$15.00
|
$ 187,500
|
SF
Capital Partners Ltd.
|
Warrants
|
10/12/2004
|
206,399
|
|
10/12/2009
|
$ 2.65
|
$ 546,957
|
Merriman
Curhan Ford & Co.
|
Warrants
|
10/12/2004
|
38,700
|
|
10/12/2009
|
$ 6.27
|
$ 242,649
|
Cypress
Semiconductor
|
Warrants
|
5/5/2005
|
505,562
|
|
5/5/2015
|
$7.772
|
$ 3,929,228
|
US
Special Opportunities Trust Plc.
|
Warrants
|
6/28/2005
|
6,667
|
|
6/28/2010
|
$ 5.00
|
$ 33,335
|
Renaissance US
Growth
Investment Trust Plc.
|
Warrants
|
6/28/2005
|
6,667
|
|
6/28/2010
|
$ 5.00
|
$ 33,335
|
Renaissance
Capital Growth &
Income Fund III
|
Warrants
|
6/28/2005
|
6,667
|
|
6/28/2010
|
$ 5.00
|
$ 33,335
|
Cypress
Semiconductor
|
Warrants
|
3/24/2006
|
1,000,000
|
|
3/24/2016
|
$ 7.50
|
$ 7,500,000
|
Renaissance
Capital Growth &
Income Fund III Fund
III
|
Warrants
|
5/26/2006
|
6,871
|
|
5/26/2011
|
$ 3.30
|
$ 22,674
|
Renaissance
US Growth
Investment Trust Plc.
|
Warrants
|
5/26/2006
|
6,871
|
|
5/26/2011
|
$ 3.30
|
$ 22,674
|
US Special Opportunities Trust
Plc.
|
Warrants
|
5/26/2006
|
6,260
|
|
5/26/2011
|
$ 3.30
|
$ 20,658
|
Renaissance
Capital Growth &
Income Fund III
|
Warrants
|
5/26/2006
|
1,718
|
|
5/26/2011
|
$ 3.30
|
$ 5,669
|
Renaissance
US Growth
Investment Trust Plc.
|
Warrants
|
5/26/2006
|
1,718
|
|
5/26/2011
|
$ 3.30
|
$ 5,669
|
US
Special Opportunities Trust Plc.
|
Warrants
|
5/26/2006
|
1,565
|
|
5/26/2011
|
$ 3.30
|
$ 5,165
|
Cypress
Semiconductor
|
Warrants
|
6/30/2006
|
500,000
|
|
6/30/2016
|
$ 7.50
|
$ 3,750,000
|
Premier
RENN US Emerging Growth Fund Ltd.
|
Warrants
|
9/21/2006
|
18,988
|
|
9/20/2011
|
$ 5.40
|
$ 102,535
|
US
Special Opportunities Trust Plc.
|
Warrants
|
9/21/2006
|
18,988
|
|
9/20/2019/20.2011
|
$ 5.40
|
$ 102,535
|
Renaissance
US Growth
Investment
Trust Plc.
|
Warrants
|
9/21/2006
|
18,988
|
|
9/20/2011
|
$ 5.40
|
$ 102,535
|
Renaissance
Capital Growth &
Income Fund III
|
Warrants
|
9/21/2006
|
18,988
|
|
9/20/2011
|
$ 5.40
|
$ 102,535
|
|
|
|
|
|
|
|
|
|
|
|
61
|
|
|
|
|
SIMTEK
CORPORATION
|
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|
|
|
|
|
|
|
|
|
Crestview
Capital Master LLC
|
Warrants
|
9/21/2006
|
32,279
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 174,307
|
Big
Bend XXVII Investments, L.P.
|
Warrants
|
9/21/2006
|
15,190
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 82,026
|
SF
Capital Partners Ltd.
|
Warrants
|
9/21/2006
|
7,595
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 41,013
|
Straus
GEPT Partners, LP
|
Warrants
|
9/21/2006
|
7,595
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 41,013
|
Straus
Partners, LP
|
Warrants
|
9/21/2006
|
7,595
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 41,013
|
A.
J. Stein Family Trust
|
Warrants
|
9/21/2006
|
3,798
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 20,509
|
A.
J. Stein Family Partnership
|
Warrants
|
9/21/2006
|
3,798
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 20,509
|
Brian
Stein
|
Warrants
|
9/21/2006
|
3,798
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 20,509
|
Toni
Stein
|
Warrants
|
9/21/2006
|
1,899
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 10,255
|
Steven
Hayes
|
Warrants
|
9/21/2006
|
7,595
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 41,013
|
Brian
Alleman
|
Warrants
|
9/21/2006
|
4,747
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 25,634
|
John
Christopher McComb
|
Warrants
|
9/21/2006
|
1,140
|
|
9/20/2019/20/2011
|
$ 5.40
|
$ 6,156
|
Cypress
Semiconductor
|
Warrants
|
12/18/2006
|
500,000
|
|
12/18/20112/18/2016
|
$ 7.50
|
$ 3,750,000
|
Total
Warrants
|
|
|
3,043,646
|
|
|
|
$21,866,695
|
Stock Option
Plans
Equity Incentive
Plan.
At the annual meeting
of stockholders on June 14, 2007, the Companys shareholders approved a new
Equity Incentive Plan (the 2007 EIP) that authorizes 2,800,000 shares that may
be granted under either incentive stock options within the meaning of Section
422 of the Internal Revenue Code of 1986 (the Code), nonqualified stock
options, restricted stock awards or other stock grants. The 2007 EIP
became effective on June 15, 2007. With the approval of the 2007 EIP, the
Company does not intend to grant further options under the Non-Qualified Stock
Option Plan described below; however, options outstanding under that plan remain
outstanding until they are exercised or expire by their terms. The 2007
EIP provides that the maximum number of shares with respect to which an
individual can receive a grant of options in a calendar year is 500,000 shares.
Options may be granted to key employees, consultants, and non-employee
directors. The 2007 EIP provides that an individual can receive grants of
both incentive options and nonqualified options. However, only employees
may be granted incentive options. The minimum exercise price for options
is 100% of the fair market value of the Companys stock on the date of grant and
a maximum term of 10 years. Generally, upon termination of employment or
service, options expire three months after termination. Incentive options
granted to an employee who holds more than 10% of the Companys stock must have
an exercise price of at least 110% of the fair market value of the Companys
stock on the date of grant and a maximum term of no more than 5 years.
The Compensation Committee (the Committee) of the Board of
Directors administers the 2007 EIP with respect to grants to employees,
consultants and non-employee directors. With respect to grants to officers
and directors, the Committee is constituted in a manner that satisfies
applicable laws and regulations, including Rule 16b-3 promulgated under the
Securities Exchange Act of 1934, as amended, and Code section 162(m). The
2007 EIP also provides that the full board of directors can perform any function
of the Committee, subject to the requirements of the NASDAQ rules and Code
section 162(m). The Committee has the authority to delegate to specified
officers of the Company the grants of stock options and other awards to
specified employees of the Company, and the Committee has delegated such
grant-making authority.
62
SIMTEK CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Each option granted under the 2007 EIP is evidenced by a written
stock option agreement. Each option holder shall become vested in the
shares underlying the option in such installments and over such period or
periods of time, if any, or upon such events, as are determined by the Committee
in its discretion and set forth in the option agreement.
As of December 31, 2007, 617,050
non-qualified stock options had been granted under the 2007 EIP. All
options granted under the 2007 EIP during 2007 will expire seven years from the
grant date. Vesting of the options is as follows:
·
If
an officer or employee has been employed for 12 months or more, stock options
will vest over 48 months at 1/48th per month, and vesting will begin immediately
at 1/48th per month for the four year period.
·
If
an officer or employee has been employed for less than 12 months, no vesting
will occur until the officer or employee has been employed for 12 months at
which time the officer or employee will be caught up at 1/48th per month for
each month since the option grant and then the options will continue to vest at
1/48th per month for the remaining portion of the four year period.
·
If
an officer or employee is a new hire, no vesting will occur until the officer or
employee has been employed for 12 months at which time the officer or employee
will receive 12/48th of the vesting and then the options will continue to vest
at 1/48th per month for the remaining portion of the four year period.
·
All
options granted to outside directors of the Company will be 100% vested after
six months from the grant date.
The Committee may
grant a participant a number of shares of restricted stock as determined by the
Committee in its sole discretion. Grants of restricted stock may be
subject to such restrictions, including for example, continuous employment with
the Company for a stated period of time or the attainment of performance goals
and objectives, as determined by the Committee in its sole discretion. The
restrictions may vary among awards and participants. As of December 31,
2007, no grants of restricted stock awards had occurred.
From time to time, in
its sole discretion, the Committee may grant awards under the 2007 EIP in
connection with one or more incentive compensation arrangements under which
participants may acquire shares of common stock by purchase, grant, or
otherwise. All such awards are subject to the terms of the 2007 EIP.
As of December 31, 2007, no other stock awards occurred.
Employee Stock Purchase
Plan.
On July 1, 2007, the
Simtek Corporation Employee Stock Purchase Plan (ESPP), which was approved by
the shareholders at the annual meeting on June 14, 2007, became effective.
Under the ESPP, a broad-based group of employees can have payroll
deductions of up to 10% of their pay used to purchase shares of the Companys
stock on a quarterly basis. However, employees whose customary employment
is for less than 20 hours per week or for less than 5 months per calendar year
and employees who own more than 5% of the Companys stock are not eligible to
participate. There are 500,000 shares authorized for issuance under the
ESPP. The purchase price for the stock is the lesser of (1) 85% of the
fair market value of the Companys stock on the first day of the calendar
quarter or (2) 85% of the fair market value
63
SIMTEK
CORPORATION
NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS
of the Companys
stock on the last day of the calendar quarter. Employees can enroll in the
ESPP as of the first day of a calendar quarter. On the first trading day
after the end of the calendar quarter, shares are purchased with the payroll
deductions accumulated during the calendar quarter. Upon termination of
employment, the employees participation in the ESPP will cease and amounts
accumulated since the beginning of the calendar quarter and not used to purchase
common stock will be refunded to the employee without interest. As of
December 31, 2007, 14 employees had enrolled in the ESPP. For the year
ended December 31, 2007, 8,986 shares of common stock were issued pursuant to
the ESPP.
Non-Qualified Stock Option
Plan.
Through June 13,
2007, the Company granted options under the 1994 Non-Qualified Stock Option Plan
(the 1994 Plan). The 1994 Plan authorized 2,060,000 non-qualified stock
options that may be granted to directors, employees, and consultants. The
plan permitted the issuance of non-statutory options and provide for a minimum
exercise price equal to 100% of the fair market value of the Company's common
stock on the date of grant. The maximum term of options granted under the
plan was 10 years and options granted to employees expire 90 days after the
termination of employment. In 2004, the Non-Qualified Stock Option Plan
was extended for 10 more years. No further options have been granted under
the 1994 Plan since the 2007 EIP became effective, and the Company does not
intend to issue any more options under the 1994 Plan in the future. All
terms and conditions of the options granted under the 1994 Plan will remain the
same. All options granted prior to March 24, 2006, began vesting after six
months after the date of grant, and will become fully vested after three years
and expire seven years from date of grant. On March 24, 2006, the Board of
Directors changed the vesting schedule of stock options granted after March 24,
2006 to be as follows:
·
If
an officer or employee has been employed for 12 months or more, stock options
will vest over 48 months at 1/48th per month, and vesting will begin immediately
at 1/48th per month for the four year period.
·
If
an officer or employee has been employed for less than 12 months, no vesting
will occur until the officer or employee has been employed for 12 months at
which time the officer or employee will be caught up at 1/48th per month for
each month since the option grant and then the options will continue to vest at
1/48th per month for the remaining portion of the four year period.
·
If
an officer or employee is a new hire, no vesting will occur until the officer or
employee has been employed for 12 months at which time the officer or employee
will receive 12/48th of the vesting and then the options will continue to vest
at 1/48th per month for the remaining portion of the four year period.
·
All
options granted to outside directors of the Company will be 100% vested after
six months from the grant date.
·
All
options will expire seven years from date of grant.
The
following table summarizes the effects of the share-based compensation resulting
from the application of SFAS No. 123 (R) to options granted and outstanding
under the 1994 Plan, the 2007 EIP and the Employee Stock Purchase Plan.
64
SIMTEK CORPORATION
NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
Income Statement
Classifications
|
|
|
|
|
|
|
|
December 31,
|
|
|
2007
|
|
|
2006
|
(in thousands
of dollars)
|
|
|
|
|
|
Research and
development
|
$
|
345
|
|
$
|
160
|
Sales and
marketing
|
|
167
|
|
|
78
|
General and
administration
|
|
894
|
|
|
304
|
|
|
|
|
|
|
Total
|
$
|
1,406
|
|
$
|
542
|
As of December 31,
2007, there was approximately $2.8 million of unrecognized compensation costs,
adjusted for estimated forfeitures, related to non-vested options granted to the
Companys employees and directors, which will be recognized through December 31,
2011. Total unrecognized compensation will be adjusted for future changes
in estimated forfeitures.
The following table
sets forth the pro forma amounts of net loss and net loss per share for the
years ended December 31, 2005 that would have resulted if we had accounted for
the stock option plans under the fair value recognition provisions of SFAS 123R.
|
|
|
|
|
|
December 31,
2005
|
(in thousands,
except per share amounts)
|
|
Net loss as
reported
|
$
(5,786)
|
Add:
Stock based compensation
included
in reported
|
-
|
Net
loss
|
(5,786)
|
Deduct:
Fair value of stock based
compensation
|
(1,294)
|
|
Pro
forma net loss
|
$
(7,080)
|
|
Net loss as
reported basic and
diluted
|
$
(.84)
|
Pro forma net
loss basic and
diluted
|
$
(1.03)
|
65
Stock options outstanding and currently exercisable at December 31,
2007 are as follows:
For grants issued
during 2007, the fair value for stock options was estimated at the date of grant
using the Black-Scholes option pricing model, which requires management to make
certain assumptions. Expected volatility was based on the historical
volatility of the Companys stock over the past 5 years. The Company based
the risk-free interest rate that was used in the option valuation mode on U.S.
Treasury notes. The Company does not anticipate paying cash dividends in
the foreseeable future and therefore use an expected dividend yield of 0%.
Cash received from
option exercises for the year ended December 31, 2007 was $21,000. The
option exercises provide a tax deduction of approximately $12,000. This
tax benefit will be charged to paid-in capital when, and if, the tax deduction
is utilized prior to expiration.
In May 2005, the
Company accelerated vesting of certain unvested and out-of-the-money stock
options previously awarded to employees and officers. Because the price of
the Companys common stock was $5.70 on the day of acceleration, the options,
which were exercisable at $6.20 and above, had no economic value on the date of
acceleration. As a result of the acceleration, options to purchase
approximately 170,000 shares of Simtek common stock became exercisable.
Options held by non-employee directors were excluded from the vesting
acceleration.
Sales from the
Companys military products accounted for approximately 8%, 8% and 15% of total
sales for the years ended December 31, 2007, 2006 and 2005, respectively.
Sales to unaffiliated
customers which represent 10% or more of the Company's sales for the years ended
December 31, 2007, 2006 and 2005 were as follows (as a percentage of sales)
:
At December 31, 2007,
the Company had gross accounts receivable totaling $2,273,000 due from the above
three customers.
In 2007, 2006 and
2005, the Company purchased all of its silicon wafers, based on 0.8 micron
technology from a single supplier, Chartered. Approximately 70%, 66% and
86% of the Company's net revenue for 2007, 2006 and 2005, respectively, were
from finished units produced from these wafers.
In 2007, 2006 and
2005, the Company purchased all of its silicon wafers, based on 0.25 micron
technology from a single supplier, Dongbu. Approximately 21%, 13% and 13%
of the Companys net revenue for 2007, 2006 and 2005, respectively, were from
finished units produced from these wafers.
In addition,
approximately 9% and 20% of the Companys net revenue was from finished units
purchased from ZMD for 2007 and 2006, respectively.
The net current and
non-current deferred tax assets have a 100% valuation allowance resulting from
the inability to predict sufficient future taxable income to utilize the assets.
The valuation allowance for 2007 increased by approximately $993,000 and
decreased by $7,897,000 in 2006. The primary reason for the decrease
in 2006 relates to the expiration of net operating losses and the Company's
assessment regarding the effects of section 382 discussed below.
At the end of 2005,
the Company underwent a change of ownership, for US federal income tax purposes,
which has the effect of limiting the Company's ability to utilize its net
operating losses in the future. As a result, approximately $10 million of
net operating losses will expire and not be utilized and, therefore, the Company
has not included this in the calculation of its deferred tax asset.
Excluding the $10 million that will expire, the Company has approximately
$18.6 million of available net operating loss carryforwards that may be utilized
in the future and which begin to expire from 2008 to 2027.
As a result of
certain non-qualified stock options which have been exercised, approximately
$4.5 million of the net operating loss carryforward will be charged to "paid-in
capital," when, and if, the losses are utilized.
Total income tax
expense for 2007, 2006 and 2005 differed from the amounts computed by applying
the U.S. Federal statutory tax rates to the pre-tax loss as follows:
The Financial
Accounting Standards Board issued Interpretation No. 48 Accounting for
Uncertainty in Income Taxesan Interpretation of FASB Statement No. 109 ("FIN
48") which requires reporting of taxes based on tax positions which meet a more
likely than not standard and which are measured at the amount that is more
likely than not to be realized. Differences between financial and tax reporting
which do not meet this threshold are required to be recorded as unrecognized tax
benefits. FIN 48 also provides guidance on the presentation of tax matters and
the recognition of potential IRS interest and penalties. The provisions of FIN
48 were adopted by the Company on January 1, 2007, and had no effect on the
Company's financial position, cash flows or results of operations upon adoption
as the Company does not have any unrecognized tax benefits. The Company also
evaluated its tax positions as of December 31, 2007 and reached the same
conclusion.
The Company
classifies penalty and interest expense related to income tax liabilities as an
income tax expense. There are no interest and penalties recognized in the
statement of operations or accrued on the balance sheet.
The Company files tax
returns in the US, in the states of California, Colorado, Georgia and Maine and
Germany. The tax years 2004 through 2007 remain open to examination by the
major taxing jurisdictions to which the Company is subject.
On August 30, 2005,
the Company, along with the Companys wholly-owned subsidiary, Q-DOT, Inc.
(Q-DOT), entered into an Asset Purchase Agreement with Hittite Microwave
Corporation (Hittite) and a wholly-owned subsidiary of Hittite, HMC
Acquisition Corporation (HMC Acquisition), whereby substantially all of the
assets of Q-DOT were sold to HMC Acquisition in exchange for a cash payment of
approximately $2.2 million. The Company realized a net gain of
approximately $1,687,000. In addition, Hittite assumed certain future
obligations of Q-DOT, including obligations related to Q-DOTs real estate lease
and certain software license agreements. Incident to the Asset Purchase
Agreement, the parties also entered an Escrow Agreement, whereby $200,000 of the
purchase price was placed in escrow for one year to secure certain
indemnification obligations of Simtek and Q-DOT. In addition, the parties
entered into a Confidentiality, Non-Disclosure and Restrictive Covenant
Agreement, whereby, among other things, Simtek and Q-DOT agreed not to compete
against Hittite and HMC Acquisition for a period of four years with respect to
certain businesses relating to Q-DOTs operations. On September 1, 2006,
the Company received the $200,000 that was placed in the escrow account.
In accordance with
SFAS No. 144, the consolidated financial statements of the Company have been
recast to present this business as a discontinued operation. Accordingly,
the revenues, the costs and expenses of the discontinued operation have been
excluded from the respective captions in the accompanying Consolidated
Statements of Operations and have been reported under the caption Income from
discontinued operations for all periods presented. In addition, certain
of the Notes to the Consolidated Financial Statements have been recast for all
periods to reflect the discontinuance of this operation.
Summary results for
the discontinued operation are as follows (in thousands):
There are no amounts
included in the December 31, 2007 Consolidated Balance Sheet related to the
discontinued operations.
On
December 30, 2005, the Company purchased from Zentrum Mikroelektronik
Dresden AG (ZMD) certain assets related to ZMDs nvSRAM product line (the ZMD
Asset Acquisition). Under the terms of various agreements between Simtek and
ZMD beginning in 1994, ZMD used Simteks proprietary technology to manufacture
and sell products that directly competed with Simteks products.
Management believes that the ZMD Asset Acquisition provided several
benefits, including consolidation of nvSRAM products in the marketplace,
increased sales volume, and control of its proprietary technology. On that
same date and in connection with the ZMD Asset Acquisition, which is described
in more detail below, Simtek and ZMD entered into a number of agreements
including a License Agreement (the New License Agreement). Pursuant to the New
License Agreement, ZMD assigned its rights in certain patents devoted to nvSRAM
to Simtek and Simtek licensed to ZMD the right to use Simteks
silicon-oxide-nitride-oxide-silicon (SONOS)-based nvSRAM technology for embedded
functions in ZMDs non-competing products. The licenses granted pursuant to the
New License Agreement are perpetual, non-exclusive, royalty-free and unlimited.
No fees or payments are due to either party under the New License Agreement. The
New License Agreement shall remain in effect on a country-by-country basis until
all patents, trade secrets, and any other proprietary and legal rights subject
thereto have expired or ended, unless terminated earlier by either party
following a breach by the other party that remains uncured after 30 days
written notice. In addition, Simtek and ZMD executed a Non-Competition and
Non-Solicitation Agreement (the NC Agreement) whereby, for a period of five
years from the closing, ZMD is prohibited from competing with certain of
Simteks products and from hiring employees of Simtek in certain situations.
In
1994, the Company licensed certain intellectual property to ZMD, which permitted
ZMD to produce nvSRAM products that directly competed with the products sold by
the Company. During the past several years, the two companies have
competed for market share with key customers, resulting in significant
reductions in average unit selling prices. The Company believed that
acquiring the assets from ZMD would result in more price stability in the
marketplace and provide additional revenue to Simtek.
The
transaction with ZMD was completed on December 30, 2005. As such, the
assets acquired are included in the accompanying Consolidated Balance Sheet as
of December 31, 2005. However, there were no results of operations related
to the assets acquired included in the Consolidated Statement of Operations for
the Year Ended December 31, 2005 as there were no operating activities until
January 2006.
The purchase price
consisted of $8 million of cash paid to ZMD, and 626,072 shares of Simtek common
stock issued to ZMD, valued at $2 million, per the terms of the agreement based
on the volume weighted average price of the common stock for the 60 trading days
prior to the execution date of the Asset Purchase Agreement on December 7, 2005.
For accounting and financial reporting purposes, the shares issued to ZMD
have been valued at $3.00 per share, pursuant to Emerging Issues Task Force
99-12 Determination of the Measurement Date for the Market Price of Acquirer
Securities Issued in a Purchase Business Combination, resulting in an
accounting value of $1,882,000. The total purchase price including
transaction related costs, amounted to $10,425,000. The transaction
related costs include $272,000 investment banking costs, $240,000 legal fees,
and $31,000 other. Following is a summary of the assets acquired.
Management determined the value assigned to each of the assets
identified above based on several factors, including among other things, unit
cost of products to be purchased from ZMD in the future, Simteks relationship
with former ZMD customers, Simteks knowledge of the design and technology of
ZMDs products, and an independent valuation of the non-competition agreement
(which will be amortized over the five year term of the agreement). No
value was assigned to the New License Agreement, because in managements
opinion, the intellectual property subject to that license is derived from the
Companys base technology and does not significantly enhance or change such
technology.
The following table
sets forth certain information related to unaudited pro forma results of
operations, as if the transaction were completed at the beginning of each period
presented (in thousands of dollars, except per share amounts):
On March 24, 2006,
the Company entered into a License and Development Agreement with Cypress
pursuant to which, among other things, Cypress agreed to license certain
intellectual property from the Company to develop and manufacture standard,
custom and embedded nvSRAM products and Cypress agreed to pay to the Company
$4,000,000 in non-refundable pre-paid royalties of which $2 million was paid
upon signing of the agreement, $1 million was paid on June 30, 2006 and $1
million was paid on December 18, 2006. In addition, the Company licensed
rights to use certain intellectual property from Cypress for use in its
products. As part of the License and Development Agreement, the Company
agreed to issue Cypress warrants to purchase 2 million shares of the Companys
common stock for $7.50 per share. The warrants have a ten year life.
The warrants were issued upon receipt of each of the prepaid royalty
amounts. The value of the warrants issued of $1,930,000 was determined
using the Black Scholes option-pricing model and has been recorded as an
increase in additional paid in capital. The net balance of the
non-refundable prepaid royalties of $2,070,000 was recognized as revenue at the
time the payments were received.
On
February 19, 2008, the Company announced the formation of its majority owned
subsidiary, AgigA Tech, Inc., a Delaware corporation (AgigA). AgigA
plans to focus on the development and commercialization of low-cost, ultra-high
density, nonvolatile random access memory (NVRAM) solutions.
Simtek
owns all of the convertible preferred stock of AgigA, which gives it voting
control of AgigA and substantially all of the economic interests in AgigA until
the occurrence of certain liquidity events. The minority stockholders are
certain employees of AgigA. In addition, as is customary for emerging
growth companies, a total of 25% of the equity has been set aside for issuance
to employees and others in connection with services to be rendered.
As
of February 13, 2008, Simtek, AgigA and Ronald Sartore entered into a Founders
Stock Agreement (the Agreement). Under the Agreement, Mr. Sartores
common stock vests over five years. Subject to certain exceptions, Mr.
Sartore must remain an employee of AgigA for vesting to occur. Mr.
Sartores common stock will become immediately vested upon an initial public
offering or change of control of AgigA. If Mr. Sartore ceases performing
services for AgigA, Sartore will immediately transfer to AgigA all shares that
have not become vested.Pursuant to the terms of the Agreement, AgigA has the
right of first refusal to acquire Mr. Sartores shares upon a proposed sale
of such shares. AgigA also has the right to acquire Mr. Sartores
shares of common stock upon his termination from employment with AgigA upon
certain circumstances. If Simtek proposes to sell a substantial portion of
its interest in AgigA, Mr. Sartore has the right to include some of his
vested shares in such sale.The Agreement provides the terms and procedures
pursuant to which Simtek will provide additional funding to AgigA.
Following is unaudited quarterly selected financial data for the
past eight quarters (in thousands of dollars, except per share amounts):